Wells Fargo
RXST icon

Wells Fargo’s RxSight RXST Stock Holding History

Wells Fargo’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Buy
40,786
+7,549
+23% +$45.6K ﹤0.01% 5218
2026
Q1 		$205K Sell
33,237
-75,294
-69% -$625K ﹤0.01% 4692
2025
Q4 		$1.13M Sell
108,531
-3,397
-3% -$34.1K ﹤0.01% 3870
2025
Q3 		$1.01M Sell
111,928
-8,559
-7% -$75.1K ﹤0.01% 3817
2025
Q2 		$1.57M Buy
120,487
+92,883
+336% +$1.4M ﹤0.01% 3398
2025
Q1 		$697K Buy
27,604
+1,030
+4% +$30.6K ﹤0.01% 3862
2024
Q4 		$914K Buy
26,574
+445
+2% +$20.1K ﹤0.01% 3773
2024
Q3 		$1.29M Sell
26,129
-21,926
-46% -$1.12M ﹤0.01% 3373
2024
Q2 		$2.89M Buy
48,055
+12,138
+34% +$694K ﹤0.01% 2687
2024
Q1 		$1.85M Buy
35,917
+11,191
+45% +$549K ﹤0.01% 3029
2023
Q4 		$997K Sell
24,726
-1,662
-6% -$48.7K ﹤0.01% 3431
2023
Q3 		$736K Sell
26,388
-1,788
-6% -$53.3K ﹤0.01% 3532
2023
Q2 		$811K Buy
28,176
+9,199
+48% +$205K ﹤0.01% 3611
2023
Q1 		$317K Buy
18,977
+5,517
+41% +$77.9K ﹤0.01% 4148
2022
Q4 		$171K Sell
13,460
-4,993
-27% -$60.7K ﹤0.01% 4263
2022
Q3 		$222K Sell
18,453
-4,138
-18% -$56.8K ﹤0.01% 4187
2022
Q2 		$318K Sell
22,591
-12,900
-36% -$170K ﹤0.01% 4020
2022
Q1 		$440K Buy
35,491
+1,843
+5% +$22.1K ﹤0.01% 4503
2021
Q4 		$379K Buy
33,648
+7,259
+28% +$87.2K ﹤0.01% 4886
2021
Q3 		$334K Buy
+26,389
New +$363K ﹤0.01% 4883

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo's RXST Position: Q2 2026 in Review

Wells Fargo increased its RxSight (RXST) stake by 23% in Q2 2026, buying an estimated $45.6K and bringing the position to 40,786 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #5218.

Wells Fargo first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.89M in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Wells Fargo held 40,786 shares of RxSight worth $197K as of Q2 2026.
  • Wells Fargo bought 7,549 RxSight shares in Q2 2026, an estimated $45.6K.
  • RxSight made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5218 holding.
  • Wells Fargo first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
  • Wells Fargo's RxSight position peaked at $2.89M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.